Delivery Order 75D30124D20062-75D30124F00002
Award Date
9/27/24
Potential Completion Date
9/26/25
Potential Value
$610K
Federal Agency
CDC Pittsburgh
Awardee
Aegis Sciences Corporation
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Nashville, TN 37228, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price delivery order to Aegis Sciences Corporation, a for-profit organization, to provide Test Surge and Data Sharing services. This order was placed under a multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract with a total ceiling value of $2,427,648.50 and a period of performance through September 26, 2029. Aegis, operating out of its laboratory in Nashville, Tennessee, will perform COVID-19...
Aegis Sciences Corporation was awarded a firm fixed price definitive contract valued at $17,982,063.34 by the National Institutes of Health's National Heart, Lung and Blood Institute to rapidly develop SARS-CoV-2 test capacity as part of the RADx program. Under the contract, Aegis Sciences, doing business as Aegis Analytical Laboratories in Nashville, Tennessee, will deliver testing services from August 2020 through August 2022 to support the National Institutes of Health's efforts to accelerate...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $1.2 million firm fixed price purchase order to Aegis Sciences Corporation of Nashville, Tennessee for genomic sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing under its Aegis Analytical Laboratories division. The contract runs from March 1, 2021 through April 15, 2021 to support genomic sequencing efforts at the CDC, likely related to...
This federal contract award is for a delivery order under the "Test Surge and Data Sharing Multiple Award IDIQ" issued by the Centers for Disease Control and Prevention (CDC). The prime contractor is Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract has a ceiling value of $449,761.53 and a completion date of May 15, 2025. It is a time and materials contract type, with no set-aside designation. The contract leverages Ginkgo Bioworks' expertise...
This federal contract award is for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Centers for Disease Control and Prevention (CDC) for "Test Surge and Data Sharing" services. The $118 million IDIQ was awarded to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts, on September 27, 2024. The contract has an ultimate completion date of September 5, 2029. This IDIQ is not designated as a set-aside contract. The IDIQ contract leverages...
The U.S. Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Quest Diagnostics Incorporated, a provider of diagnostic information services, for a "Test Surge and Data Sharing" program. The $493,118 contract has a period of performance through September 2025 and is a time and materials type contract. This IDIQ vehicle allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Laboratory Corporation of America (Labcorp), a leading global life sciences company. The contract is part of a larger multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) vehicle called the "TEST SURGE MULTIPLE AWARD IDIQ," which has a total ceiling value of $4,286,480.04. The contract is a firm-fixed-price delivery order with a period of performance ending on September...
This is a $6,631,042.24 Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Quest Diagnostics Incorporated by the Centers for Disease Control and Prevention (CDC) to provide test surge and data sharing services. The contract has an ultimate completion date of September 26, 2029. This IDIQ contract is part of the broader "Test Surge and Data Sharing Multiple Award IDIQ" and does not have a set-aside designation. Under this contract, Quest Diagnostics will provide a...
This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
This is a $311,100 time and materials delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Eagle Global Scientific LLC, an Atlanta-based company that provides professional and technical services to federal agencies. The order is for comprehensive epidemiological, public health, laboratory, and administrative support services for the CDC's Respiratory Viruses Branch. This delivery order is under a larger $25 million single-award IDIQ contract held by Eagle Global...